{
  "actions": [
    {
      "acted_at": "2011-04-01", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2011-04-07", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr1316-112", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "112", 
  "cosponsors": [
    {
      "district": "13", 
      "name": "Buchanan, Vern", 
      "sponsored_at": "2011-04-01", 
      "state": "FL", 
      "thomas_id": "01840", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "8", 
      "name": "Fitzpatrick, Michael G.", 
      "sponsored_at": "2012-03-20", 
      "state": "PA", 
      "thomas_id": "01797", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "9", 
      "name": "Lynch, Stephen F.", 
      "sponsored_at": "2011-04-01", 
      "state": "MA", 
      "thomas_id": "01686", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "14", 
      "name": "Mack, Connie", 
      "sponsored_at": "2011-04-01", 
      "state": "FL", 
      "thomas_id": "01776", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "5", 
      "name": "Rogers, Harold", 
      "sponsored_at": "2011-04-01", 
      "state": "KY", 
      "thomas_id": "00977", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "10", 
      "name": "Wolf, Frank R.", 
      "sponsored_at": "2011-04-01", 
      "state": "VA", 
      "thomas_id": "01238", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2011-04-01", 
  "number": "1316", 
  "official_title": "To direct the Commissioner of Food and Drugs to modify the approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for the relief of severe-only instead of moderate-to-severe pain, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Stop Oxy Abuse Act of 2011", 
  "sponsor": {
    "district": "45", 
    "name": "Bono Mack, Mary", 
    "state": "CA", 
    "thomas_id": "01465", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2011-04-01", 
  "subjects": [
    "Drug safety, medical device, and laboratory regulation", 
    "Health", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2011-04-01", 
    "text": "Stop Oxy Abuse Act of 2011 - Directs the Commissioner of Food and Drugs (FDA), within 90 days, to take such actions as may be necessary to modify the approval of, and limit any subsequent approval of, any drug containing controlled-release oxycodone hychloride to use for the relief of severe-only pain instead of moderate-to-severe pain. Applies any such modification to drugs introduced into interstate commerce 180 days after enactment of this Act."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Stop Oxy Abuse Act of 2011", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To direct the Commissioner of Food and Drugs to modify the approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for the relief of severe-only instead of moderate-to-severe pain, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-20T01:21:45-04:00"
}